Circulating miR-30 is related to carotid artery atherosclerosis

Yuqing Huang1, Jiyan Chen1, Yingling Zhou1

  • 1a Department of Cardiology , Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology , Guangzhou , China.

Insights

Lower levels of miR-30 were found in hypertensive patients and those with increased carotid intima-media thickness (CIMT). This suggests miR-30 may serve as a biomarker for atherosclerosis in hypertension.

Area of Science:

  • Cardiovascular Disease Research
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Hypertension is a major risk factor for cardiovascular diseases, including atherosclerosis.
  • Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis.
  • MicroRNAs (miRNAs) are implicated in the pathogenesis of cardiovascular diseases.

Purpose of the Study:

  • To investigate the association between miR-30 expression and blood pressure parameters.
  • To evaluate the relationship of miR-30 with carotid intima-media thickness (CIMT).
  • To determine if miR-30 can serve as a biomarker for atherosclerosis in hypertensive patients.

Main Methods:

  • Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to measure miR-30 expression in 40 hypertensive patients and 40 controls.
  • Carotid artery ultrasonography to assess CIMT.
  • Office and ambulatory blood pressure monitoring.
  • Spearman correlation and logistic regression analyses to assess associations.

Main Results:

  • Hypertensive patients exhibited significantly lower miR-30 expression compared to healthy controls.
  • Lower miR-30 levels were also observed in individuals with increased CIMT.
  • miR-30 expression showed a significant negative correlation with 24-hour systolic blood pressure, 24-hour diastolic blood pressure, office systolic blood pressure, and CIMT.

Conclusions:

  • Circulating miR-30 levels are reduced in patients with essential hypertension and atherosclerosis.
  • miR-30 may function as a potential biomarker for identifying atherosclerosis in individuals with hypertension.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
715
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K